Innova Captab Ltd

Innova Captab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Innova Captab Ltd

₹ 881 -0.74%
10 Jun 12:39 p.m.
innovacaptab.com BSE: 544067 NSE: INNOVACAP
About

Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.[1]

Key Points

Business Profile[1]
Innova Captab Limited is an integrated pharmaceutical player with a strong presence across the pharmaceutical value chain

Website BSE NSE
  • Market Cap ₹ 5,040 Cr.
  • Current Price ₹ 881
  • High / Low ₹ 1,260 / 479
  • Stock P/E 39.3
  • Book Value ₹ 168
  • Dividend Yield 0.00 %
  • ROCE 14.6 %
  • ROE 14.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 35.7% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
242 242 241 233 283 302 263 294 318 316 315
211 208 214 202 242 258 225 252 268 270 267
Operating Profit 31 34 27 31 40 45 38 42 50 47 48
OPM % 13% 14% 11% 13% 14% 15% 14% 14% 16% 15% 15%
2 3 3 1 3 2 6 2 2 4 3
Interest 5 6 5 5 9 7 1 0 0 0 2
Depreciation 3 3 3 3 5 5 3 5 5 5 10
Profit before tax 25 28 21 25 30 35 40 39 47 46 39
Tax % 24% 31% 19% 28% 24% 29% 27% 25% 25% 25% 25%
19 20 17 18 23 25 29 29 35 34 30
EPS in Rs 3.91 4.08 3.59 3.66 4.77 4.39 5.02 5.15 6.12 5.98 5.17
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
356 373 411 801 926 1,081 1,244
315 322 356 704 813 927 1,058
Operating Profit 41 51 54 96 114 154 186
OPM % 11% 14% 13% 12% 12% 14% 15%
0 1 1 3 9 12 12
Interest 6 5 4 6 20 21 2
Depreciation 11 10 6 8 11 16 25
Profit before tax 25 38 46 86 92 130 171
Tax % 20% 26% 26% 25% 26% 27% 25%
20 28 34 64 68 94 128
EPS in Rs 165.67 232.42 287.50 532.92 14.16 16.49 22.41
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 27%
3 Years: 16%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 36%
3 Years: 26%
TTM: 36%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 80%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 17%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 12 12 12 12 48 57 57
Reserves 70 98 133 197 229 774 902
72 54 46 199 237 245 338
68 81 179 167 191 240 283
Total Liabilities 223 245 370 575 704 1,316 1,580
78 73 79 183 183 358 830
CWIP 0 0 7 0 22 341 23
Investments 0 0 0 0 0 0 0
144 172 283 392 500 617 728
Total Assets 223 245 370 575 704 1,316 1,580

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
19 31 42 59 67 146 64
-9 -6 -20 -188 -91 -499 -152
-9 -23 -19 125 27 361 92
Net Cash Flow 1 1 3 -5 3 8 4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 93 85 123 97 104 97 97
Inventory Days 50 84 107 76 77 91 93
Days Payable 80 92 132 86 105 113 90
Cash Conversion Cycle 64 77 99 87 77 75 100
Working Capital Days 77 86 73 97 98 88 110
ROCE % 26% 28% 31% 24% 19% 15%

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
50.90% 50.90% 50.90% 50.90% 50.90% 50.90%
3.57% 1.94% 1.19% 1.01% 0.74% 0.35%
10.31% 20.78% 21.24% 20.61% 19.96% 19.77%
35.22% 26.39% 26.67% 27.48% 28.41% 29.00%
No. of Shareholders 1,39,11739,39635,11532,25436,69239,996

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls